GILD31 quarters
Position history for
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in GILEAD SCIENCES INC
Yes. UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS holds 12,986,591 shares of GILD (Gilead Sciences), worth $1.6B, as of its Q2 2026 13F filing. It reduced the position by 212,512 shares (-1.6%) from Q1 2026. UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS has held GILD in every 13F on record since Q4 2018, 31 quarterly filings. GILD is 0.3% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS' reported 13F portfolio.
Current Value
$1.6B
Current Shares
13M
Total Value Change
+$1.3B
Total Shares Change
+6.9M
Other major holders of GILD: BlackRock, Inc., VANGUARD GROUP INC